Loading...
•
Dec 31, 2020
Schrodinger Q4 2020 Earnings Report
Schrödinger reported revenue growth driven by software uptake and strategic collaborations.
Key Takeaways
Schrödinger reported a 28% increase in total revenue for Q4 2020, driven by strong software revenue growth and contributions from a strategic collaboration with Bristol Myers Squibb. The company ended the year with a solid financial position, enabling continued investment in its computational platform and internal pipeline.
Total revenue increased by 28% in the fourth quarter of 2020.
Software revenue increased by 42% in the fourth quarter of 2020.
Entered into a strategic collaboration with Bristol Myers Squibb, receiving $55 million upfront.
Ended the fourth quarter with $643.2 million in cash, cash equivalents, restricted cash and marketable securities.
Revenue by Segment
Forward Guidance
Schrödinger expects total revenue to range from $124 million to $142 million, with software revenue expected to range from $102 million to $110 million, and drug discovery revenue expected to range from $22 million to $32 million for the fiscal year ended December 31, 2021.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...